Search - tctmd.com

Displaying 601 - 620 of 924

Sort: Relevancy | Date

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

Presentation TCT 2016

Risk Scores: Development, Validation, Utility, and Limitations (With Case Studies: Framingham, TIMI/GRACE, CHADS/HASBLED, DAPT, and Others)

Presenter: Scott Berry, Stuart J. Pocock, Ajay J. Kirtane

October 30, 2016

Presentation TCT 2016

Strengths and Limitations of Risk Scores to Identify Patients for Long vs Short DAPT

Presenter: John A. Bittl, Daniel I. Simon, Roxana Mehran

October 30, 2016

Presentation TCT 2016

Flash Debate: Counterpoint The Emergence of TAVR Risk Scores Are a Better Solution to Patient Selection!

Presenter: Patrick T. O'Gara, Alec S. Vahanian, David J. Cohen

October 30, 2016

Presentation TCT 2016

Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Christopher B. Granger

October 30, 2016

News Daily News

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Yael L. Maxwell

October 28, 2016

News Daily News

Red Meat and Dairy Gut Metabolite Linked to Higher Mortality in PAD Patients

Michael O'Riordan

October 20, 2016

News Daily News

Experience Matters: Patients of High-Volume Operators Have Lower Mortality Rates After Left Main PCI

Michael O'Riordan

October 18, 2016

News Daily News

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Michael O'Riordan

October 07, 2016

News Daily News

Post-TAVR Cognition Improves in Some Patients and Declines in Others, With Few Signposts to Guide the Way

Shelley Wood

September 29, 2016

News Daily News

CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study

Michael O'Riordan

September 22, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shelley Wood

September 20, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Daily News

Patient-Level Data Supports PCI for Some Patients with Unprotected Left Main Disease

Yael L. Maxwell

September 07, 2016

News Conference News ESC 2016

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Michael O'Riordan

August 28, 2016

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

L.A. McKeown

August 24, 2016

News Daily News

Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy

Michael O'Riordan

August 23, 2016

News Daily News

Neighborhood Access to Healthy Food Affects Residents’ Risk of Atherosclerosis

Leah Lawrence

August 22, 2016

News Daily News

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

Yael L. Maxwell

August 03, 2016

News Daily News

Simple Risk-Scoring System Predicts Mortality After TAVR

Michael O'Riordan

July 25, 2016

Advertisement

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Risk Scores: Development, Validation, Utility, and Limitations (With Case Studies: Framingham, TIMI/GRACE, CHADS/HASBLED, DAPT, and Others)

Strengths and Limitations of Risk Scores to Identify Patients for Long vs Short DAPT

Flash Debate: Counterpoint The Emergence of TAVR Risk Scores Are a Better Solution to Patient Selection!

Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Red Meat and Dairy Gut Metabolite Linked to Higher Mortality in PAD Patients

Experience Matters: Patients of High-Volume Operators Have Lower Mortality Rates After Left Main PCI

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Post-TAVR Cognition Improves in Some Patients and Declines in Others, With Few Signposts to Guide the Way

CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Patient-Level Data Supports PCI for Some Patients with Unprotected Left Main Disease

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy

Neighborhood Access to Healthy Food Affects Residents’ Risk of Atherosclerosis

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

Simple Risk-Scoring System Predicts Mortality After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content